Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries

NCT04572906 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Neuraptive Therapeutics Inc.